10x Genomics (TXG) Assets Average (2019 - 2026)

10x Genomics (TXG) has 8 years of Assets Average data on file, last reported at $1.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 12.9% year-over-year to $1.0 billion; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (up 12.9% YoY), and the FY2025 full-year result was $980.0 million, up 4.05% from the prior year.
• Assets Average retreated to $1.0 billion in Q1 2026, from $1.0 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.0 billion in Q4 2025 to a low of $911.0 million in Q1 2025.
• A 5-year average of $978.0 million and a median of $998.9 million in 2022 frame the typical range for Assets Average.
• Across the five-year window, Assets Average retreated 7.58% in 2024 and grew 12.9% in 2026, its largest moves.
• Tracing TXG's Assets Average over 5 years: stood at $1.0 billion in 2022, then slipped by 5.51% to $956.8 million in 2023, then decreased by 2.99% to $928.2 million in 2024, then gained by 11.44% to $1.0 billion in 2025, then fell by 0.56% to $1.0 billion in 2026.
• Business Quant data shows TXG's Assets Average at $1.0 billion in Q1 2026, $1.0 billion in Q4 2025, and $1.0 billion in Q3 2025.